HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Activation of the activin A-ALK-Smad pathway in systemic sclerosis.

Abstract
Systemic sclerosis (SSc) is a chronic disease of unknown etiology that is characterized by multiple tissue fibrosis. Transforming Growth Factor-beta (TGF-β) is thought to be the most important mediator that induces fibrosis. However, the molecular mechanisms by which fibrosis is induced have not been fully elucidated. In this study, the role of activin, a member of the TGF-β superfamily, was investigated in the pathogenesis of fibrosis in SSc. Serum activin A levels in patients with SSc were measured by ELISA, and the expression of the activin receptor type IB (ACVRIB/ALK4) and the activity of the signaling pathway via ACVRIB/ALK4 were investigated using western blotting. To evaluate a potential therapeutic strategy for SSc, we also attenuated the ACVRIB/ALK4 pathway using an inhibitor. Serum activin A levels were significantly higher in SSc patients than in normal controls. Activin A and ACVRIB/ALK4 expression were also higher in cultured SSc fibroblasts. Activin A stimulation induced phosphorylation of Smad2/3 and CTGF expression in SSc fibroblasts. Procollagen production and Col1α mRNA also increased upon stimulation by activin A. The basal level of Smad2/3 phosphorylation was higher in cultured SSc fibroblasts than in control cells, and treatment with the ALK4/5 inhibitor SB431542 prevented phosphorylation of Smad2/3 and CTGF expression. Furthermore, production of collagen was also induced by activin A. Activin A-ACVRIB/ALK4-Smad-dependent collagen production was augmented in SSc fibroblasts, suggesting the involvement of this signaling mechanism in SSc. Inhibition of the activin A-ACVRIB/ALK4-Smad pathway would be a new approach for the treatment of SSc.
AuthorsKae Takagi, Yasushi Kawaguchi, Manabu Kawamoto, Yuko Ota, Akiko Tochimoto, Takahisa Gono, Yasuhiro Katsumata, Masatoshi Takagi, Masako Hara, Hisashi Yamanaka
JournalJournal of autoimmunity (J Autoimmun) Vol. 36 Issue 3-4 Pg. 181-8 (May 2011) ISSN: 1095-9157 [Electronic] England
PMID21377836 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
CopyrightCopyright © 2010 Elsevier Ltd. All rights reserved.
Chemical References
  • SMAD2 protein, human
  • SMAD3 protein, human
  • Smad2 Protein
  • Smad3 Protein
  • Transforming Growth Factor beta
  • activin A
  • Activins
  • Nitric Oxide
  • Collagen
  • ACVR1B protein, human
  • Activin Receptors, Type I
Topics
  • Activin Receptors, Type I (antagonists & inhibitors, physiology)
  • Activins (physiology)
  • Cells, Cultured
  • Collagen (biosynthesis)
  • Fibroblasts (metabolism)
  • Humans
  • Nitric Oxide (biosynthesis)
  • Scleroderma, Systemic (drug therapy, etiology, metabolism)
  • Signal Transduction
  • Smad2 Protein (physiology)
  • Smad3 Protein (physiology)
  • Transforming Growth Factor beta (physiology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: